Jan Beyer-Westendorf et al.
The Lancet. Haematology, 7(12), e884-e891 (2020-11-27)
Direct oral anticoagulants (DOACs) have largely replaced vitamin K antagonists in many indications for anticoagulation. Prescribed to millions of patients, including women of reproductive age, exposure to DOACs in early pregnancy is not uncommon, but data on the embryotoxic risks